Earnings Feed
Start Free
Home/Filings/4/0001144204-08-059193
4//SEC Filing

MEDICAL SOLUTIONS MANAGEMENT INC. 4

Accession 0001144204-08-059193

CIK 0000104401operating
View on SEC.govCompany Profile

Filed

Oct 23, 8:00 PM ET

Accepted

Oct 24, 1:21 PM ET

Size

29.3 KB

Accession

0001144204-08-059193

Insider Transaction Report

Form 4
Period: 2008-07-30
MEDICAL SOLUTIONS MANAGEMENT INC.MSMT
Vicis Capital, LLC
Other
Transactions
  • Purchase

    Common Stock, $0.0001, par value per share

    2008-08-29$0.26/sh+15,000$3,900→ 41,297,577 total(indirect: By Vicis Capital Master Fund)
  • Other

    Series D Convertible Preferred Stock, par value $0.0001

    2008-07-30+79,890,600→ 798,906 total(indirect: By Vicis Capital Master Fund)
    Exercise: $0.10→ Common Stock (79,890,600 underlying)
  • Purchase

    Common Stock, $0.0001, par value per share

    2008-09-17$0.20/sh+70,000$14,000→ 41,367,577 total(indirect: By Vicis Capital Master Fund)
  • Purchase

    Common Stock, $0.0001, par value per share

    2008-08-29$0.24/sh+20,000$4,800→ 41,282,577 total(indirect: By Vicis Capital Master Fund)
Holdings

  • Warrant to Purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.20Exp: 2010-12-30→ Common Stock (120,000 underlying)
    120,000

  • Series A Warrant to Purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.20Exp: 2011-02-28→ Common Stock (146,667 underlying)
    146,667

  • Senior Secured Convertible Debenture

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.10Exp: 2008-06-28→ Common Stock (20,000,000 underlying)
    20,000,000

  • Warrant to Purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.20Exp: 2012-03-16→ Common Stock (153,000 underlying)
    153,000

  • Series B Warrant to Purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.20Exp: 2011-02-28→ Common Stock (146,667 underlying)
    146,667

  • Series CS Warrant to Purchase Common Stock No. CS-13

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.50Exp: 2012-12-07→ Common Stock (3,060,000 underlying)
    3,060,000

  • Warrant to Purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.20Exp: 2012-04-17→ Common Stock (1,560,000 underlying)
    1,560,000

  • Warrant to Purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.20Exp: 2011-12-30→ Common Stock (544,935 underlying)
    544,935

  • Series CS Warrant to Purchase Common Stock No. CS-14

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.40Exp: 2012-12-16→ Common Stock (2,500,000 underlying)
    2,500,000

  • Senior Secured Convertible Debenture

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.10Exp: 2009-04-17→ Common Stock (10,500,000 underlying)
    10,500,000
Vicis Capital Master Fund
Other
Transactions
  • Other

    Series D Convertible Preferred Stock, par value $0.0001

    2008-07-30+79,890,600→ 798,906 total(indirect: By Vicis Capital Master Fund)
    Exercise: $0.10→ Common Stock (79,890,600 underlying)
  • Purchase

    Common Stock, $0.0001, par value per share

    2008-08-29$0.26/sh+15,000$3,900→ 41,297,577 total(indirect: By Vicis Capital Master Fund)
  • Purchase

    Common Stock, $0.0001, par value per share

    2008-09-17$0.20/sh+70,000$14,000→ 41,367,577 total(indirect: By Vicis Capital Master Fund)
  • Purchase

    Common Stock, $0.0001, par value per share

    2008-08-29$0.24/sh+20,000$4,800→ 41,282,577 total(indirect: By Vicis Capital Master Fund)
Holdings

  • Senior Secured Convertible Debenture

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.10Exp: 2008-06-28→ Common Stock (20,000,000 underlying)
    20,000,000

  • Series B Warrant to Purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.20Exp: 2011-02-28→ Common Stock (146,667 underlying)
    146,667

  • Series CS Warrant to Purchase Common Stock No. CS-13

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.50Exp: 2012-12-07→ Common Stock (3,060,000 underlying)
    3,060,000

  • Series CS Warrant to Purchase Common Stock No. CS-14

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.40Exp: 2012-12-16→ Common Stock (2,500,000 underlying)
    2,500,000

  • Warrant to Purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.20Exp: 2010-12-30→ Common Stock (120,000 underlying)
    120,000

  • Series A Warrant to Purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.20Exp: 2011-02-28→ Common Stock (146,667 underlying)
    146,667

  • Warrant to Purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.20Exp: 2011-12-30→ Common Stock (544,935 underlying)
    544,935

  • Warrant to Purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.20Exp: 2012-04-17→ Common Stock (1,560,000 underlying)
    1,560,000

  • Warrant to Purchase Common Stock

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.20Exp: 2012-03-16→ Common Stock (153,000 underlying)
    153,000

  • Senior Secured Convertible Debenture

    (indirect: By Vicis Capital Master Fund)
    Exercise: $0.10Exp: 2009-04-17→ Common Stock (10,500,000 underlying)
    10,500,000
Footnotes (4)
  • [F1]Immediately.
  • [F2]Represents the indirect holdings of Vicis Capital LLC. All of the foregoing represents securities held directly by Vicis Capital Master Fund. Vicis Capital LLC acts as investment advisor to Vicis Capital Master Fund and therefore has voting and dispositive power over all the foregoing shares. For the purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, Vicis Capital LLC may be deemed to be the beneficial owner of, but hereby disclaims such beneficial ownership of, the foregoing shares.
  • [F3]None.
  • [F4]On July 29, 2008 Vicis Capital Master Fund acquired from the Issuer: (1) 300,000 shares of the Issuer's Series D Convertible Preferred Stock, par value $0.0001 per share, convertible into 30,000,000 shares of the Issuer's common stock for a cash purchase price of $3,000,000; and (2) 498,906 shares of the Issuer's Series D Convertible Preferred Stock, convertible into 49,890,600 shares of the Issuer's common stock, in exchange for Vicis Capital Master Fund tendering, delivering and forgiving certain existing debts of the Issuer in the principal amount of $4,760,204.91 and accrued interest of $228,856.63.

Documents

1 file

Issuer

MEDICAL SOLUTIONS MANAGEMENT INC.

CIK 0000104401

→
Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0000104401

Filing Metadata

Form type
4
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 1:21 PM ET
Size
29.3 KB
View on SEC.gov